"Les équipes de l’Institut de Radiothérapie et de Radiochirurgie H. Hartmann accueillent avec compétence et bienveillance les patients en mettant à leur disposition l’excellence médicale et technologique. Leader français en secteur libéral avec plus de 3200 traitements par an, l’Institut de Radiothérapie et de Radiochirurgie H. Hartmann collabore avec plusieurs établissements privés du territoire pour assurer la prise en charge en chirurgie, chimiothérapie et soins de suite en cancérologie."

During the past decade, Clinique Hartmann conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Hartmann" #1 sponsor was "UNICANCER" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored and "Centre Oscar Lambret" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Hartmann" #1 collaborator was "National Cancer Institute, France" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Aquilab SAS" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Hartmann" are "Breast Cancer" (4 trials), "Metastatic Breast Cancer" (2 trials), "Prostate Cancer" (2 trials), "Bone Metastases" (1 trials) and "Breast Cancer Female" (1 trials). Many other conditions were trialed in "Clinique Hartmann" in a lesser frequency.

Most popular intervention types in "Clinique Hartmann" are "Drug" (8 trials), "Biological" (3 trials), "Radiation" (2 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Biodegradable balloon implant" (1 trials), "CHEMOTHERAPY then HORMONOTHERAPY" (1 trials), "Carboplatin" (1 trials) and "Docetaxel every 3 weeks + Prednisone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Hartmann" are 7 trials for "Female" genders, 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Hartmann". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Clinique Hartmann, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Hartmann, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".